Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression

Código QR

Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression

Taina&ecirc; Santos,1 Monaliza Marizete Baungratz,1 Suellen Priscila Haskel,2 Daniela Delwing de Lima,3 J&uacute;lia Niehues da Cruz,4 D&eacute;bora Delwing Dal Magro,5 Jos&eacute; Geraldo Pereira da Cruz51Department of Medicine, 2Department of Physiotherapy, Regional...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Santos T, Baungratz MM, Haskel SP, de Lima DD, da Cruz JN, Dal Magro DD, da Cruz JG
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/7de616d675d24f1ca5c7c5e67572258a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
por: Zou C, et al.
Publicado: (2013)

Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
por: Yin B, et al.
Publicado: (2019)

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial
por: Che T, et al.
Publicado: (2018)

Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
por: William&nbsp;V Bobo, et al.
Publicado: (2009)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
por: Huang J, et al.
Publicado: (2018)

Current Perception Threshold Testing in Pharyngeal Paresthesia Patients with Depression or Anxiety
por: Chang W, et al.
Publicado: (2020)

The hospital anxiety and depression scale, in patients with multiple sclerosis
por: Pais-Ribeiro JL, et al.
Publicado: (2018)

Current Perception Threshold Testing in Pharyngeal Paresthesia Patients with Depression or Anxiety [Corrigendum]
por: Chang W, et al.
Publicado: (2020)

Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine
por: Elizabeth A. Pekarskaya, et al.
Publicado: (2021)

Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan S, et al.
Publicado: (2017)

Contributing roles of depression, anxiety, and impulsivity dimensions in eating behaviors styles in surgery candidates
por: Farid Benzerouk, et al.
Publicado: (2021)

Adaptive Affect: The Nature of Anxiety and Depression
por: Morris DW
Publicado: (2019)

The Toronto Hospital Alertness Test scale: relationship to daytime sleepiness, fatigue, and symptoms of depression and anxiety
por: Shahid A, et al.
Publicado: (2016)

Factors related to depression and anxiety in adults with bronchiectasis
por: Özgün Niksarlioglu EY, et al.
Publicado: (2016)

Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
por: Francisco J. Flores-Ramirez, et al.
Publicado: (2021)

The noradrenergic paradox: implications in the management of depression and anxiety
por: Montoya A, et al.
Publicado: (2016)

Effects of Polyphenol Supplementations on Improving Depression, Anxiety, and Quality of Life in Patients With Depression
por: Kelly Lin, et al.
Publicado: (2021)

Addictive potential of novel treatments for refractory depression and anxiety
por: Kolar D
Publicado: (2018)

Medical expert testimony as conflict of interest regarding the onset of rheumatoid arthritis following trauma
por: Sherry DD
Publicado: (2016)

Sleep cognitions associated with anxiety and depression in the elderly
por: Leblanc MF, et al.
Publicado: (2015)

The relationship between sleep habits, anxiety, and depression in the elderly
por: Leblanc MF, et al.
Publicado: (2015)

The effect of fluoxetine and imipramine on the improvement of depressive-like behaviors and HPA axis (hypothalamic-pituitary-adrenal cortex) activity – an animal model
por: Raghad Abdulsalam Khaleel, et al.
Publicado: (2021)

Assessment of anxiety and depression after lower limb amputation in Jordanian patients
por: Ziad M Hawamdeh, et al.
Publicado: (2008)

Stress, anxiety, and depression among medical students in a multiethnic setting
por: Kulsoom B, et al.
Publicado: (2015)

Stress, anxiety, and depression among parents of children with autism spectrum disorder in Oman: a case–control study
por: Al-Farsi OA, et al.
Publicado: (2016)

Depression and Anxiety Disorders in Child and Adolescent Populations in Low and Middle Income Countries: A Review
por: S. Yatham, et al.
Publicado: (2017)

Anxiety and depression in patients with osteoarthritis: impact and management challenges
por: Sharma A, et al.
Publicado: (2016)

Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
por: Jesús K. Yamamoto-Furusho, et al.
Publicado: (2021)

Comparing telehealth-based and clinic-based group cognitive behavioral therapy for adults with depression and anxiety: a pilot study
por: Khatri N, et al.
Publicado: (2014)

A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
por: Wu R, et al.
Publicado: (2015)

Response to depression treatment in the Aging Brain Care Medical Home model
por: LaMantia MA, et al.
Publicado: (2016)

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
por: Rinaldi A, et al.
Publicado: (2019)

Post-weaning Social Isolated Flinders Sensitive Line Rats Display Bio-Behavioural Manifestations Resistant to Fluoxetine: A Model of Treatment-Resistant Depression
por: Khulekani Mncube, et al.
Publicado: (2021)

The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes
por: Jeff C Huffman, et al.
Publicado: (2010)

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
por: Prasko J, et al.
Publicado: (2016)

Anxiety and depression levels in prepubertal obese children: a case-control study
por: Esposito M, et al.
Publicado: (2014)

Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia
por: Nicholas Don-Doncow, et al.
Publicado: (2021)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
por: Novick D, et al.
Publicado: (2016)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang KD, et al.
Publicado: (2017)